Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.

by Li, Yanjing, He, Yiping, Butler, William, Xu, Lingfan, Chang, Yan, Lei, Kefeng, Zhang, Hong, Zhou, Yinglu, Gao, Allen C, Zhang, Qingfu, Taylor, Daniel G, Cheng, Donghui, Farber-Katz, Suzette, Karam, Rachid, Landrith, Tyler, Li, Bing, Wu, Sitao, Hsuan, Vickie, Yang, Qing, Hu, Hailiang, Chen, Xufeng, Flowers, Melissa, McCall, Shannon J, Lee, John K, Smith, Bryan A, Park, Jung Wook, Goldstein, Andrew S, Witte, Owen N, Wang, Qianben, Rettig, Matthew B, Armstrong, Andrew J, Cheng, Qing, Huang, Jiaoti
Published 2019